USH1G Antibodies

Santa Cruz Biotechnology offers a broad range of USH1G monoclonal antibodies for research focused on understanding USH1G protein functions. USH1G monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). USH1G, also known as Usher syndrome type 1G protein, plays a critical role in the development and function of sensory cells in the inner ear and retina. Mutations in the USH1G gene are associated with Usher syndrome, a condition characterized by hearing loss and vision impairment, highlighting USH1G's importance in sensory perception. Understanding USH1G function is essential for advancing research into potential therapeutic strategies for related disorders. Researchers can utilize USH1G monoclonal antibodies to investigate protein expression patterns across different tissues and cellular compartments. Current studies focus on exploring USH1G's role in cellular signaling pathways and its interactions with other proteins involved in sensory development. Investigating USH1G's molecular mechanisms may lead to breakthroughs in treating sensory disorders. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of USH1G and its role in human health and disease.